The anti-fibrotic effect of GV1001 combined with gemcitabine on treatment of pancreatic ductal adenocarcinoma

GV1001 is a telomerase-based cancer vaccine made of a 16-mer telomerase reverse transcriptase (TERT) peptide, and human TERT, the rate-limiting subunit of the telomerase complex, is an attractive target for cancer vaccination. The aim of this study was to evaluate the effect of telomerase peptide va...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncotarget
Hauptverfasser: Park, Joo Kyung, Kim, Yejin, Kim, Hyemin, Jeon, Jane, Kim, Tae Wan, Park, Ji-Hong, Hwnag, Young-il, Lee, Wang Jae, Kang, Jae Seung
Format: Artigo
Sprache:Inglês
Veröffentlicht: Impact Journals LLC 2016
Schlagworte:
Research Paper
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5342724/
https://ncbi.nlm.nih.gov/pubmed/27655706
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12057
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge